HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Miguel Martín Selected Research

talazoparib

2/2020Poly (ADP-ribose) Polymerase Inhibition in Patients with Breast Cancer and BRCA 1 and 2 Mutations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Miguel Martín Research Topics

Disease

92Breast Neoplasms (Breast Cancer)
04/2024 - 02/2003
50Neoplasms (Cancer)
04/2024 - 01/2007
8Neoplasm Metastasis (Metastasis)
04/2022 - 06/2008
6Disease Progression
03/2024 - 10/2005
6Pathologic Complete Response
03/2024 - 06/2015
6Triple Negative Breast Neoplasms
03/2024 - 05/2018
6Cardiotoxicity
01/2023 - 01/2009
2Residual Neoplasm
01/2022 - 11/2017
2Fatigue
10/2021 - 07/2010
2Hand-Foot Syndrome
01/2021 - 05/2014
2Melanoma (Melanoma, Malignant)
10/2020 - 07/2014
2Ovarian Neoplasms (Ovarian Cancer)
01/2020 - 02/2011
2Neutropenia
01/2018 - 03/2007
2Colorectal Neoplasms (Colorectal Cancer)
03/2016 - 05/2014
2Prostatic Neoplasms (Prostate Cancer)
01/2016 - 01/2016
2Circulating Neoplastic Cells
01/2013 - 11/2006
2Febrile Neutropenia
03/2007 - 07/2004
1Hypothyroidism
02/2024
1Acquired Immunodeficiency Syndrome (AIDS)
09/2023
1Cross Infection (Nosocomial Infection)
09/2022
1Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1Nausea
10/2021
1Dihydropyrimidine Dehydrogenase Deficiency
08/2021
1Cholangiocarcinoma
06/2021
1Renal Cell Carcinoma (Grawitz Tumor)
10/2020
1Necrosis
10/2020

Drug/Important Bio-Agent (IBA)

26Hormones (Hormone)IBA
10/2023 - 01/2007
18AnthracyclinesIBA
03/2024 - 02/2003
13Docetaxel (Taxotere)FDA Link
06/2021 - 07/2004
12Trastuzumab (Herceptin)FDA Link
04/2024 - 10/2005
11Capecitabine (Xeloda)FDA Link
01/2023 - 06/2005
9Taxoids (Taxanes)IBA
09/2021 - 02/2003
8human ERBB2 proteinIBA
02/2024 - 01/2013
8ErbB Receptors (EGF Receptor)IBA
10/2023 - 01/2012
8Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2009
8Paclitaxel (Taxol)FDA LinkGeneric
05/2019 - 06/2008
6Estrogen ReceptorsIBA
03/2024 - 10/2012
6Phenobarbital (Luminal)FDA Link
09/2023 - 10/2012
5Fulvestrant (Faslodex)FDA Link
03/2024 - 03/2015
5Aromatase InhibitorsIBA
03/2024 - 01/2012
5ribociclibIBA
01/2023 - 01/2018
5130-nm albumin-bound paclitaxelIBA
06/2019 - 06/2013
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2015 - 06/2008
4taxaneIBA
04/2024 - 01/2016
4Immunoconjugates (Immunoconjugate)IBA
02/2024 - 01/2016
4thiamine triphosphorate (TTP)IBA
04/2022 - 10/2005
4PlatinumIBA
01/2020 - 02/2011
4Doxorubicin (Adriamycin)FDA LinkGeneric
07/2013 - 07/2004
3Circulating Tumor DNAIBA
10/2023 - 12/2019
3palbociclibIBA
01/2023 - 10/2021
3Letrozole (Femara)FDA LinkGeneric
05/2022 - 03/2015
3Carboplatin (JM8)FDA LinkGeneric
12/2018 - 01/2017
3Bevacizumab (Avastin)FDA Link
01/2018 - 01/2012
3DenosumabFDA Link
01/2016 - 10/2013
3Epirubicin (Ellence)FDA LinkGeneric
11/2015 - 06/2008
3Fluorouracil (Carac)FDA LinkGeneric
07/2013 - 06/2008
2trastuzumab deruxtecanIBA
04/2024 - 02/2024
2AntibodiesIBA
02/2024 - 01/2019
2TamoxifenFDA LinkGeneric
10/2023 - 01/2013
2abemaciclibIBA
10/2023 - 09/2023
2Genetic Markers (Genetic Marker)IBA
01/2023 - 01/2023
2Messenger RNA (mRNA)IBA
01/2023 - 10/2016
2pertuzumabIBA
01/2023 - 06/2021
2Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2022 - 02/2020
2DNA (Deoxyribonucleic Acid)IBA
09/2021 - 04/2011
2liposomal doxorubicin (Doxil)FDA Link
09/2021 - 07/2010
2neratinibIBA
06/2020 - 06/2012
2Anastrozole (Arimidex)FDA LinkGeneric
08/2019 - 01/2012
2Progesterone Receptors (Progesterone Receptor)IBA
04/2018 - 01/2013
2Proteins (Proteins, Gene)FDA Link
11/2017 - 01/2013
2Albumin-Bound PaclitaxelFDA Link
11/2017 - 06/2013
2Vinorelbine (Navelbine)FDA LinkGeneric
03/2007 - 02/2003
1giredestrantIBA
03/2024
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
03/2024
1Formaldehyde (Formol)FDA Link
01/2023
1Cyclin-Dependent Kinase 4IBA
01/2023
1ParaffinIBA
01/2023
1SolutionsIBA
12/2022
1sacituzumab govitecanIBA
12/2022
1Codon (Codons)IBA
01/2022
1spartalizumabIBA
01/2022
1Olive OilIBA
01/2022
1BO-112IBA
10/2020
1Fatty Acids (Saturated Fatty Acids)IBA
10/2020
1NivolumabIBA
10/2020
1Phospholipids (Phosphatides)FDA LinkGeneric
10/2020
1Poly I-CIBA
10/2020
1pembrolizumabIBA
10/2020
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
02/2020

Therapy/Procedure

54Therapeutics
03/2024 - 06/2005
39Drug Therapy (Chemotherapy)
03/2024 - 02/2003
9Neoadjuvant Therapy
04/2024 - 08/2009
8Adjuvant Chemotherapy
01/2020 - 01/2007
3Precision Medicine
05/2019 - 11/2017
3Radiotherapy
09/2015 - 01/2012
2Intravenous Infusions
01/2020 - 10/2016
2Induction Chemotherapy
07/2011 - 07/2010
1Lymph Node Excision (Lymph Node Dissection)
02/2023
1Hand Hygiene
09/2022
1Drug Tapering
01/2021